BioCentury
ARTICLE | Company News

Axogen Ltd., Elan deal

November 4, 1996 8:00 AM UTC

Elan created Axogen, a wholly owned R&D subsidiary, to develop products for neurological disorders, with an initial focus on multiple sclerosis. ...